109 filings
Page 2 of 6
8-K
puclgbm6
18 Apr 23
Regulation FD Disclosure
8:00am
8-K
kuyhtmduo3o1b
15 Mar 23
Matinas BioPharma Reports 2022 Financial Results and Provides a Business Update
4:05pm
8-K
xoo ed6e5o0
30 Jan 23
Matinas BioPharma Provides Business Update and 2023 Strategic Outlook
4:00pm
8-K
l3k4orkp8c gb6qwc5
12 Jan 23
Regulation FD Disclosure
6:59am
8-K
4hl5c
29 Dec 22
Regulation FD Disclosure
7:00am
8-K
niaekt vcacr
14 Nov 22
Submission of Matters to a Vote of Security Holders
5:15pm
8-K
7mljb9k qxm9
2 Nov 22
Matinas BioPharma Reports Third Quarter 2022 Financial Results and Highlights Recent Progress
4:05pm
8-K
om9z8n 4va9
21 Oct 22
Matinas BioPharma Announces Positive Interim Data from the Phase 2
7:00am
8-K
h465ui 9m2
13 Sep 22
Regulation FD Disclosure
7:00am
8-K
1oeyd1 kbo7
11 Aug 22
Matinas BioPharma Reports Second Quarter 2022 Financial Results and Highlights Recent Progress
6:25am
8-K
e2au510m m2
12 May 22
Matinas BioPharma Reports First Quarter 2022 Financial Results and Operational Highlights
6:30am
8-K
q62aj g7m1j0
13 Apr 22
Regulation FD Disclosure
8:43am
8-K
yigtzpjn sn
11 Apr 22
BioNTech and Matinas BioPharma Announce Exclusive Research Collaboration to Evaluate Novel Delivery Technology for mRNA-based Vaccines
7:00am
8-K
bxccm kwoytli
8 Mar 22
Matinas BioPharma Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
6:30am
8-K
r10z4zi
25 Jan 22
Matinas BioPharma Provides Business Update and 2022 Strategic Outlook
6:30am
8-K
jx6gmcj ye1odw8he0z4
16 Dec 21
Regulation FD Disclosure
6:30am
8-K
3xt2qu8wr4f8 53f
6 Dec 21
Matinas BioPharma Appoints Thomas Hoover, M.B.A. as Chief Business Officer
6:30am
8-K
e32t0lw195b2z9sjwj5
8 Nov 21
Matinas BioPharma Reports Third Quarter 2021 Financial Results and Operational Highlights
6:35am
8-K
jaxnh 85ro736
1 Nov 21
Submission of Matters to a Vote of Security Holders
5:15pm
8-K
p022u7ru0g33p7pnt86q
20 Sep 21
Matinas BioPharma Announces Accomplished Biotechnology Executive and Drug Developer Kathryn Penkus Corzo as Nominee to the Board of Directors
7:05am